A prospective study on buprenorphine use during pregnancy: Effects on maternal and neonatal outcome

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 2, 2007, Pages 185-190

  Kahila, Hanna ^a   Saisto, Terhi ^a,b   Kivitie Kallio, Satu ^c   Haukkamaa, Maija ^a   Halmesmäki, Erja ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Buprenorphine maintenance; Fetal buprenorphine exposure; Neonatal abstinence syndrome; Sudden infant death syndrome

Indexed keywords

BUPRENORPHINE; MORPHINE; PHENOBARBITAL;

ADULT; APGAR SCORE; ARTICLE; BIRTH; CESAREAN SECTION; CONTROLLED STUDY; DELIVERY; DRUG DEPENDENCE TREATMENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FETUS GROWTH; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; INCIDENCE; LOW BIRTH WEIGHT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNITY WARD; MEDICAL SPECIALIST; MIDWIFE; MORPHINE ADDICTION; MOTHER; NEWBORN; NEWBORN CARE; NURSE; OBSTETRICS; OUTPATIENT; PH MEASUREMENT; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DEPARTMENT; REFERENCE VALUE; SOCIAL WORKER; STATISTICS; SUDDEN INFANT DEATH SYNDROME; TREATMENT OUTCOME; UMBILICAL ARTERY; WITHDRAWAL SYNDROME;

BIRTH WEIGHT; BUPRENORPHINE; FEMALE; HEPATITIS C ANTIBODIES; HUMANS; INFANT, NEWBORN; MORPHINE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SMOKING; SUDDEN INFANT DEATH;

EID: 33846998348     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340601110770     Document Type: Article

References (24)

1. Finnegan LP. Perinatal substance abuse: comments and perspectives. [Review] [40 refs]. Semin Perinatol. 1991;15(4):331-9.
2. Shankaran S, Das A, Bauer CR, Bada HS, Lester B, Wright LL, et al. Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics. 2004;114(2):226-34.
3. Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol. 1990;163(5 Pt 1):1535-42.
4. Schneiderman JF. Nonmedical drug and chemical use in pregnancy. In: Schneiderman JF, editor. Maternal-fetal toxicology: a clinician's guide, Second edition. New York: M Dekker; 1994. p. 301-19.
5. Brown HL, Britton KA, Mahaffey D, Brizendine E, Hiett AK, Turnquest MA. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol. 1998;179(2):459-63.
6. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, et al. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction. 2000;95(2):239-44.
7. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003;98(1):103-10.
8. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2 Suppl):S87-S101.
9. Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction. 2004;99(2):209-14.
10. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S, the Groupe d'Etudes Grossesse et Addictions (GEGA). Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or highdose buprenophine substitution. Drug Alcohol Depend. 2006;82(3):250-7.
11. El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol. 2003;23(5):354-60.
12. Finnegan LP. Neonatal abstinence syndrome. In: Nelson N, editor. Current therapy in neonatal-perinatal medicine, First edition. Ontario: BC Decker Inc; 1984. p. 314-20.
13. Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth curves in Finland]. [Review] [18 refs]. Duodecim. 1989;105(18):1540-6.
14. Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.[see comment]. Lancet. 2003;361(9358):662-8.
15. Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol. 1996;20(6):369-78.
16. Robinson SE. Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny. Neurotoxicol Teratol. 2002;24(2):137-42.
17. Belcheva MM, Bohn LM, Ho MT, Johnson FE, Yanai J, Barron S, et al. Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine. Brain Res Dev Brain Res. 1998;111(1):35-42.
18. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology. 2002;42(6):829-36.
19. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002;110(6):1182-92.
20. Gourarier L, Lorene C, Aubisson S, Peyret E. 1998-1999 substitution treatment and birth among heroin dependent women in France: a prospective study about 249 cases. Drug Alcohol Depend. 2001;63(Supplement):58.
21. Kayemba-Kays S, Laclyde JP. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction. 2003;98(11):1599-604.
22. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol. 2002;100(6):1244-9.
23. Kandall SR, Gaines J, Habel L, Davidson G, Jessop D. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr. 1993;123(1):120-6.
24. Suguihara C, Bancalari E. Substance abuse during pregnancy: effects on respiratory function in the infant. [Review] [70 refs]. Semin Perinatol. 1991;15(4):302-9.